601 results on '"Penack, Olaf"'
Search Results
2. How risky is a second allogeneic stem cell transplantation?
3. ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
4. Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia
5. ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party
6. The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
7. Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study
8. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT
9. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
10. Data-driven grading of acute graft-versus-host disease
11. Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
12. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
13. Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
14. Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
15. Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis
16. EASIX-1year and late mortality after allogeneic stem cell transplantation
17. ATG or no ATG? – survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT
18. Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT
19. CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
20. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
21. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study
22. Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
23. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force
24. Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
25. GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany
26. Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT
27. HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party
28. Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT
29. PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
30. Editorial: Emerging talents in alloimmunity and transplantation: 2022
31. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults
32. Introducing Matchgraft.AI: Machine Learning Based Risk-Prediction-Tool for Severe Complications of Allogenic Hematopoietic Stem Cell Transplantation (HSCT) like Acute Graft Versus Host Disease (aGvHD), Relapse or All Cause Mortality (ACM)
33. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
34. Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts
35. Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
36. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)
37. Editorial - Emerging talents in alloimmunity and transplantation: 2022
38. How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT
39. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
40. Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
41. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
42. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
43. Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
44. ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party
45. The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
46. Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study
47. Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study
48. The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
49. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry
50. EASIX and mortality after allogeneic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.